Moreover, because of the post-translational nature of HIF1α (and HIF2α) regulation, our RNA-seq findings could be improved by studying the protein levels of both HIF1α and HIF2α at the intestinal mucosa of patients with IBD. This evidence concerns the gene EPAS1 and inflammatory bowel disease.